Showing 1,621 - 1,640 results of 2,274 for search '"type 2 diabetes"', query time: 0.14s Refine Results
  1. 1621

    SGLT-2 Inhibitors—a Culprit of Diabetic Ketoacidosis Postbariatric Surgery by Qasim Zafar Iqbal, Danil Mishiyev, Muhammad Raphay Niazi, Zeeshan Zia, Saud Bin Abdul Sattar, Abdullah Jahanghir, Shahed Quyyumi

    Published 2020-01-01
    “…We present a case series of three cases of euglycemic DKA postbariatric surgery in patients with an underlying history of type 2 diabetes mellitus, who were being treated with SGLT2 inhibitors prior to the surgery. …”
    Get full text
    Article
  2. 1622

    The Beneficial Effects of GLP-1 Receptor Agonists Other than Their Anti-Diabetic and Anti-Obesity Properties by Chenqi Lu, Cong Xu, Jun Yang

    Published 2024-12-01
    “…GLP-1 receptor (GLP-1R) agonists are synthetic products that have similar effects to GLP-1 but are less prone to degradation, and they are widely used in the treatment of type 2 diabetes and obesity. In recent years, different beneficial effects of GLP-1R agonists were discovered, such as reducing ischemia-reperfusion injury, improving the function of various organs, alleviating substance use disorder, affecting tumorigenesis, regulating bone metabolism, changing gut microbiota composition, and prolonging graft survival. …”
    Get full text
    Article
  3. 1623

    Sarcoid of the Upper Humerus Found Incidentally on MR Images Obtained for Work-Up of Rotator Cuff Tear Where Compromised Tissue Quality Was a Concern for Surgical Success by Tanner R. Henrie, John G. Skedros

    Published 2018-01-01
    “…Her medical history includes type 2 diabetes, depression, and fatigue. She had chronic shoulder pain that worsened after her dog jerked on the leash. …”
    Get full text
    Article
  4. 1624

    Investigation of Pharmacokinetic Parameters of Trelagliptin in Egyptian Volunteers Using Sensitive LC-MS/MS: A Comparative Study with a Japanese Population by Shereen Mowaka, Nermeen Ashoush, Mariam M. Tadros, Bassam M. Ayoub

    Published 2021-01-01
    “…Trelagliptin (TLN) is a novel once-weekly antidiabetic drug that enhanced the patient compliance in type 2 diabetes. TLN analysis and bioanalysis literature review showed many methods for TLN assay either in dosage form or as biological fluids (pharmacokinetic parameters), but all those methods did not consider the full details dealing with biological assay of TLN. …”
    Get full text
    Article
  5. 1625

    Pattern Visual Evoked Potential Changes in Diabetic Patients without Retinopathy by Ozgur Balta, Gulten Sungur, Mehmet Yakin, Nurten Unlu, Oyku Bezen Balta, Firdevs Ornek

    Published 2017-01-01
    “…Fifty-eight eligible patients with type 2 diabetes mellitus and 26 age- and sex-matched healthy controls were included in the study. …”
    Get full text
    Article
  6. 1626

    Visfatin/Nampt: An Adipokine with Cardiovascular Impact by Tania Romacho, Carlos F. Sánchez-Ferrer, Concepción Peiró

    Published 2013-01-01
    “…Enhanced circulating visfatin/Nampt levels have been reported in metabolic diseases, such as obesity and type 2 diabetes. Moreover, visfatin/Nampt circulating levels correlate with markers of systemic inflammation. …”
    Get full text
    Article
  7. 1627

    Hypertriglyceridemic Waist Phenotype in Adolescents Aged 15 to 18 Years by Caridad Hernández Gutiérrez, Elodia Rivas Alpízar, Teresita Rodríguez Izaguirre, Alain Francisco Morejón Giraldoni

    Published 2015-09-01
    “…<strong>Background:</strong> presence of the hypertriglyceridemic waist phenotype is a predictor of cardiometabolic deterioration, increased type 2 diabetes mellitus and coronary heart disease.<br /> <strong>Objective:</strong> to determine the hypertriglyceridemic waist phenotype in adolescents aged 15 to 18 years from the Area III of Cienfuegos. …”
    Get full text
    Article
  8. 1628

    Primary Signet-Ring Cell Adenocarcinoma of the Urinary Bladder Treated with Partial Cystectomy: A Case Report and Review of the Literature by Umesh Jayarajah, D. M. Hilary Fernando, Kasun Bandara Herath, M. V. Chandu de Silva, S. A. S. Goonewardena

    Published 2017-01-01
    “…A 71-year-old female with a history of type 2 diabetes, hypertension, and ischaemic heart disease presented with painless haematuria for 2 months’ duration. …”
    Get full text
    Article
  9. 1629

    Cytokines and HCV-Related Disorders by Poupak Fallahi, Clodoveo Ferri, Silvia Martina Ferrari, Alda Corrado, Domenico Sansonno, Alessandro Antonelli

    Published 2012-01-01
    “…The most important systemic HCV-related extrahepatic diseases—mixed cryoglobulinemia, lymphoproliferative disorders, thyroid autoimmune disorders, and type 2 diabetes—are associated with a complex dysregulation of the cytokine/chemokine network, involving proinflammatory and Th1 chemokines. …”
    Get full text
    Article
  10. 1630

    Nocturnal Light Pollution Synergistically Impairs Glucose Metabolism With Age and Weight in Monkeys by Shuxing Wang, Xuange Cheng, Zihao Liang, Zhenyi Chen, Jiankai Zhang, Qiang Xu

    Published 2024-01-01
    “…Over the past decades, the global prevalence of Type 2 diabetes mellitus (T2D) and impaired glucose tolerance (IGT) has been increasing at an epidemic rate, yet the exact cause remains unknown. …”
    Get full text
    Article
  11. 1631

    Physical activity at home during the COVID-19 lockdown in India: Need of the hour for optimum physical health and psychological resilience by Suraj CHAWLA, Manisha KOCHER

    Published 2020-07-01
    “…It can reduce high blood pressure, help manage overweight, improve immune regulation, reduce the risk of getting heart disease, type 2 diabetes, stroke, and various cancers- all conditions which increase vulnerability to COVID-19. …”
    Get full text
    Article
  12. 1632

    Evaluation of the Obesity Prevention, Blood Glucose, and Blood Lipid Control of Vietnamese Rice Varieties in High-Fat Diet-Induced Obese Mice by Thuy Linh Nguyen, Khanh Son Trinh

    Published 2021-01-01
    “…The results obtained from this study help patients with overweight, obesity, and type 2 diabetes choose the right rice variety for their daily diet to be able to control their diseases.…”
    Get full text
    Article
  13. 1633

    Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human Diabetes by Anna Weiser, Pieter Giesbertz, Hannelore Daniel, Britta Spanier

    Published 2018-01-01
    “…The New Zealand obese (NZO) mouse is a polygenic model for obesity and diabetes with obese females and obese, diabetes-prone males, used to study traits of the metabolic syndrome like type 2 diabetes mellitus (T2DM), obesity, and dyslipidaemia. …”
    Get full text
    Article
  14. 1634

    Asymptomatic Urinary Abnormalities Among Unselected Adults in a Rural Community in Bauchi, Northeast Nigeria by Abdu Alhaji, Ibrahim M. Maigari, Hamisu Abdulrasheed, Umar Murtala, Binta A. Lasan, Sambo B. Zailani

    Published 2024-07-01
    “…Hyperglycemia was seen in 2.5% of the subjects, including two subjects who were known to have type 2 diabetes mellitus on oral hypoglycemic agents. …”
    Get full text
    Article
  15. 1635

    Functional Stability of Plasminogen Activator Inhibitor-1 by Songul Yasar Yildiz, Pinar Kuru, Ebru Toksoy Oner, Mehmet Agirbasli

    Published 2014-01-01
    “…The biological effects of PAI-1 extend far beyond thrombosis including its critical role in fibrotic disorders, atherosclerosis, renal and pulmonary fibrosis, type-2 diabetes, and cancer. The conversion of PAI-1 from the active to the latent conformation appears to be unique among serpins in that it occurs spontaneously at a relatively rapid rate. …”
    Get full text
    Article
  16. 1636

    Protective Effects of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, against Cisplatin-Induced Nephrotoxicity in Mice by Seung Hee Choi, Jaechan Leem, In-Kyu Lee

    Published 2017-01-01
    “…Dipeptidyl peptidase-4 (DPP-4) inhibitors are widely used antihyperglycemic agents for the treatment of type 2 diabetes mellitus. Recently, the pleiotropic actions of DPP-4 inhibitors have drawn much attention. …”
    Get full text
    Article
  17. 1637

    Potential Therapeutic Drugs for Parkinson’s Disease Based on Data Mining and Bioinformatics Analysis by Chuan Xu, Jiajun Chen, Xia Xu, Yingyu Zhang, Jia Li

    Published 2018-01-01
    “…Results showed that metformin hydrochloride and other drugs had certain therapeutical effect on Parkinson’s disease, and melbine (DMBG) can be used for treatment of Parkinson’s disease and type 2 diabetes patients.…”
    Get full text
    Article
  18. 1638

    Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report by Lulu Chu, Zhenhua Xi, Runzhi Ma, Weiliang Shi, Guoshen Yu

    Published 2025-01-01
    “…Case presentation We report severe EuDKA with metabolic encephalopathy secondary to dapagliflozin in a type 2 diabetes mellitus(T2DM) patient.A 72-year-old female was found unconscious 70 minutes ago.Laboratory evaluation revealed a severe metabolic acidosis with an elevated anion gap, and ketones were elevated in the blood and positive in the urine. …”
    Get full text
    Article
  19. 1639

    Effects of Bariatric Surgeries on Fetuin-A, Selenoprotein P, Angiopoietin-Like Protein 6, and Fibroblast Growth Factor 21 Concentration by Jakub Poloczek, Wojciech Kazura, Ewa Kwaśnicka, Janusz Gumprecht, Jerzy Jochem, Dominika Stygar

    Published 2021-01-01
    “…It is also associated with the leading causes of death, including type 2 diabetes mellitus, cardiovascular diseases, and numerous types of cancer. …”
    Get full text
    Article
  20. 1640

    Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome by P. Stiefel, A. J. Vallejo-Vaz, S. García Morillo, J. Villar

    Published 2011-01-01
    “…Finally, overweight and obesity promote the adrenal secretion of aldosterone, increasing the predisposition to type 2 diabetes mellitus. Further studies are needed to better establish therapeutic strategies that act on the blockade of mineralocorticoid receptor in the treatment and prevention of cardiovascular diseases related to the excess of aldosterone and the metabolic syndrome.…”
    Get full text
    Article